Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ramar Krishnamurty

2PUBLICATIONS

4CO-AUTHORS

PharmacogenomicsMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Nov 14, 2022

Friedelin, a novel inhibitor of CYP17A1 in prostate cancer from <i>Cassia tora</i>.

Bhrugesh Pravinchandra Joshi, Vishwambhar Vishnu Bhandare, Mahima Vankawala

|Feb 28, 2022

Molecular modelling studies and identification of novel phytochemical inhibitor of DLL3.

Bhrugesh Pravinchandra Joshi, Vishwambhar Vishnu Bhandare, Prittesh Patel

Pageof 1

Frequent Collaborators

2 joint publications

Bhrugesh Pravinchandra Joshi

2 joint publications

Vishwambhar Vishnu Bhandare

2 joint publications

Prittesh Patel

1 joint publications

Rajesh Patel

Frequent Collaborators

2 joint publications

Bhrugesh Pravinchandra Joshi

2 joint publications

Vishwambhar Vishnu Bhandare

2 joint publications

Prittesh Patel

1 joint publications

Rajesh Patel

Top Related Videos

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on : Nov 22, 2024

See more related videos

Top Related Videos

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Network Pharmacology Prediction and Experimental Validation of <em>Trichosanthes</em>-<em>Fritillaria thunbergii</em> Action Mechanism Against Lung Adenocarcinoma

Published on : Mar 03, 2023

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology

Published on : Nov 22, 2024

See more related videos